BD Multi-Check CD4 Low Control Recalled for Inaccurate Flow Cytometry Results
Becton, Dickinson and Company is recalling 619 vials of BD Multi-Check CD4 Low Control due to unexpected cell populations that may cause inaccurate flow cytometry results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential inaccurate test results rather than direct physical injury or death, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Becton, Dickinson and Company, BD Biosciences, is recalling 619 vials of BD Multi-Check CD4 Low Control 2.5 mL IVD. This product is intended as a complete process control for immunophenotyping by flow cytometry. The recall affects Lot Number BM1020L and includes specific catalog numbers and UDI codes for both US and international distribution.
The recall was initiated due to recent product complaints indicating an unexpected cell population exhibiting dim CD3 expression. This issue may result in inaccurate results during the gating process of flow cytometry analysis. The affected product was distributed worldwide, including nationwide in the United States and in specific countries such as Canada, Belgium, Korea, India, Ecuador, Japan, Costa Rica, Australia, Vietnam, Pakistan, Singapore, Thailand, and Peru.
Healthcare facilities and laboratories using this product should stop using the affected vials immediately. Users should contact Becton, Dickinson and Company for instructions on how to return the product or obtain a replacement. The recall is classified as Class II by the FDA, indicating a reasonable probability that the use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- BD" Multi-Check CD4 Low Control 2.5 mL IVD - Product Usage: intended as a complete process control for immunophenotyping by flow cytometry.
- Manufacturer
- Becton, Dickinson and Company, BD Biosciences
- Hazard
- Affected units
- 619
Distribution
Related recalls
Same manufacturer · Becton, Dickinson and Company, BD Biosciences
See all →- HighBD Multitest 6-Color TBNK Reagent Contamination May Cause Erroneous Results
FDA (Devices) · 2024-07-24
- HighMedical diagnostic reagent recall: incorrect cell staining fluorescence
FDA (Devices) · 2024-01-17
- HighBD Trucount Tubes Recalled Due to Partial Label Detachment Causing Operational Failures
FDA (Devices) · 2022-11-09
- HighBD Trucount Tubes for Blood Testing Recall Due to Label Detachment
FDA (Devices) · 2022-11-09
- ModerateBD Multitest 6-Color TBNK tubes recalled for partial label detachment
FDA (Devices) · 2022-11-09
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
FDA (Devices) · 2026-05-06